VSIG1 Antikörper (AA 1-80)
-
- Target Alle VSIG1 Antikörper anzeigen
- VSIG1 (V-Set and Immunoglobulin Domain Containing 1 (VSIG1))
-
Bindungsspezifität
- AA 1-80
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VSIG1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Unconjugated Rabbit polyclonal to VSIG1
- Spezifität
- VSIG1 Polyclonal Antibody detects endogenous levels of protein.
- Aufreinigung
- VSIG1 antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human VSIG1 protein.
- Isotyp
- IgG
- Top Product
- Discover our top product VSIG1 Primärantikörper
-
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) antibody
VSIG1 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (AA 293-322), (C-Term) antibodyVSIG1 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB30174 unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) antibodyVSIG1 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (AA 50-230) antibodyVSIG1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (AA 293-322) antibodyVSIG1 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (AA 71-120) antibodyVSIG1 Reaktivität: Human, Pferd, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (N-Term) antibodyVSIG1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (N-Term) antibodyVSIG1 Reaktivität: Human, Pferd, Schwein, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-V-Set and Immunoglobulin Domain Containing 1 (VSIG1) (AA 300-330), (C-Term) antibodyVSIG1 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:500-2000 ELISA 1:5000-20000
- Kommentare
-
Detected only in stomach mucosa and testis, and to a much lesser level in pancreas (at protein level). Detected in gastric cancers (31%), esophageal carcinomas (50%) and ovarian cancers (23%).
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid form in PBS containing 50 % glycerol,and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- VSIG1 (V-Set and Immunoglobulin Domain Containing 1 (VSIG1))
- Andere Bezeichnung
- VSIG1 (VSIG1 Produkte)
- Synonyme
- VSIG1 antikoerper, vsig1 antikoerper, CHT1 antikoerper, 1700062D20Rik antikoerper, GPA34 antikoerper, dJ889N15.1 antikoerper, 4930405J24Rik antikoerper, ctx antikoerper, ctx-A antikoerper, gpa34 antikoerper, V-set and immunoglobulin domain containing 1 antikoerper, V-set and immunoglobulin domain containing 1 L homeolog antikoerper, VSIG1 antikoerper, vsig1 antikoerper, Vsig1 antikoerper, vsig1.L antikoerper
- Molekulargewicht
- 42 kDa
- Gen-ID
- 340547
- UniProt
- Q86XK7
-
